NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-029-2019-0-AU-04 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION AU National Stage 2020211922 Pending
NCI E-029-2019-0-CN-06 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION CN National Stage 202080010373.0 Pending
NCI E-029-2019-0-US-10 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION US National Stage 17/424,591 Pending
NHLBI E-191-2020-0-PCT-02 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT PCT PCT PCT/US2021/042380 Expired
NCI E-029-2019-0-JP-08 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION JP National Stage 2021-542206 Pending
NHLBI E-191-2020-0-IL-05 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT IL National Stage 299776 Pending
NIAID E-215-2016-1-US-04 PREFUSION PIV F IMMUNOGENS AND THEIR USE US DIV 17/378,587 11845778 Issued PDF
NIAID E-032-2019-0-US-07 Nanoparticle-Based Influenza Virus Vaccines and Uses Thereof US National Stage 17/423,565 Pending
NCI E-029-2019-0-CA-05 HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION CA National Stage 3127096 Pending
NIA E-249-2016-0-KR-18 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE KR DIV 10-2021-7022385 Issued
NCI E-055-2017-0-US-07 Combination Therapy of Immunotoxin and Checkpoint Inhibitor US CON 17/376,319 Abandoned
NCI E-172-2020-0-PCT-02 HLA Class-II Restricted DRB1*01:01 T-cell Receptors Against The RASG12V Mutation PCT PCT PCT/US2021/041737 Expired
NCI E-195-2018-0-US-03 DETECTION OF BCL-2 FAMILY HETERODIMER COMPLEXES AND USE THEREOF US National Stage 17/422,972 Pending
NCI E-103-2010-1-EP-04 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins EP DIV 21185510.1 Pending
NICHD E-185-2020-0-PCT-02 Multidimensional MRI Signature For Specific Detection Of Traumatic Brain Injury In Vivo PCT PCT PCT/US2021/041663 Expired
NCI E-028-2019-0-US-06 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-1 AND METHODS OF USE US National Stage 17/422,609 12122843 Issued PDF
NHLBI E-127-2020-0-PCT-02 METHODS TO PRODUCE VERY LONG CHAIN FATTY ACIDS PCT PCT PCT/US2021/041381 Expired
NIAID E-096-2019-0-US-03 HUMAN IMMUNODEFICIENCY VIRUS-SPECIFIC T CELL RECEPTORS US National Stage 17/422,523 Pending
NCI E-165-2020-0-PCT-02 HLA Class-II Restricted DRB T-cell Receptors Against The RASG12D Mutation PCT PCT PCT/US2021/041375 Expired
NHLBI E-122-2021-1-US-01 PHOSPHODIESTERASE 4D LONG FORM ISOFORM INHIBITORS FOR THE TREATMENT OF LIVER FIBROSIS US 63/221,077 Abandoned
NCI E-494-2013-0-US-26 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 17/372,927 11376318 Issued PDF
NCI E-494-2013-0-US-28 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 17/373,130 11338032 Issued PDF
NCI E-494-2013-0-US-27 METHODS OF PREPARING ANTI-HUMAN PAPILLOMAVIRUS ANTIGEN T CELLS US CON 17/373,093 11331385 Issued PDF
NICHD E-169-2020-0-PCT-02 COMPOUND EMBODIMENTS FOR USE AS GPR101 LIGANDS AND METHODS OF USING THE SAME FOR TREATING HORMONAL-BASED GROWTH DISORDERS PCT PCT PCT/US2021/041294 Expired
NHLBI E-206-2020-0-PCT-02 Devices And Methods For Cerclage Of Luminal Systems PCT PCT PCT/US2021/041310 Expired
NHLBI E-206-2020-0-EP-01 Devices And Methods For Cerclage Of Luminal Systems EP National Stage 21837310.8 Pending
NHLBI E-206-2020-0-IL-01 Devices And Methods For Cerclage Of Luminal Systems IL National Stage 299587 Pending
NHLBI E-206-2020-0-JP-01 Devices And Methods For Cerclage Of Luminal Systems JP National Stage 2023-500441 Pending
NHLBI E-206-2020-0-AU-01 Devices And Methods For Cerclage Of Luminal Systems AU National Stage 2021304368 Pending
NCI E-263-2014-0-AU-11 Methods To Eliminate Cancer Stem Cells By Targeting CD47 AU DIV 2021204818 Issued
NIAID E-279-2011-0-US-04 METHODS OF PRODUCING T CELL POPULATIONS ENRICHED FOR STABLE REGULATORY T-CELLS US DIV 17/371,589 Pending
NEI E-059-2020-0-PCT-02 Cell Lines that Produce Human Retinoschisin Proteins and Uses Thereof PCT PCT PCT/US2021/040790 Expired
NICHD E-170-2020-0-PCT-02 Time Efficient Multi-pulsed Field Gradient (mPFG) MRI Without Concomitant Gradient Field Artifacts PCT PCT PCT/US2021/040929 Expired
NCI E-040-2019-0-US-07 Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors US National Stage 17/421,334 Pending
NEI E-164-2021-0-US-01 SINGLE DOMAIN ANTIBODY INHIBITS EXPANSION OF PATHOGENIC TH17 RESPONSES AND SUPPRESSION OF UVEITIS US 63/219,161 Abandoned
NIAID E-052-2017-4-ZA-55 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection ZA DIV 2021/04695 Pending
NCI E-282-2016-2-JP-01 Methods For Pre-conditioning Patients For Cell Therapy JP DIV 2021-110476 Issued
NIAID E-145-2015-4-US-03 Substituted Phenylpyrrolecarboxamides With Therapeutic Activity In HIV US CON 17/366,920 Abandoned
NEI E-071-2020-0-PCT-02 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME PCT PCT PCT/US2021/040157 Expired
NINDS E-120-2020-2-PCT-01 ADAPTABLE DUAL-TUNED OPTICALLY CONTROLLED ON-COIL AMPLIFIER FOR HIGH-FIELD MAGNETIC RESONANCE IMAGING SYSTEMS PCT PCT COMB PCT/US2021/040117 Expired
NEI E-071-2020-0-EP-06 CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION EP National Stage 21751672.3 Pending
NEI E-071-2020-0-CA-05 COMPOUND EMBODIMENTS FOR TREATING RETINAL DEGENERATION AND METHOD EMBODIMENTS OF MAKING AND USING THE SAME CA National Stage 3186586 Pending
NCI E-199-2023-0-US-01 TREATMENTS FOR DIFFUSE LARGE B-CELL LYMPHOMA US 63/216,777 Expired
NIAID E-131-2015-2-US-49 NEUTRALIZING ANTIBODIES TO GP120 AND THEIR USE US CON 17/358,522 Abandoned
NCATS E-244-2014-0-JP-12 Small Molecule Inhibitors Of Lactate Dehydrogenase and Methods of Use Thereof JP DIV 2021-103894 Issued
NCI E-264-2015-0-US-06 MONOCLONAL ANTIBODIES SPECIFIC FOR FIBROBLAST GROWTH FACTOR RECEPTOR 4 (FGFR4) AND METHODS OF THEIR USE US DIV 17/355,703 Pending
NCI E-152-2020-0-PCT-02 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST CD20 PCT PCT PCT/US2021/038649 Expired
NHLBI E-091-2021-0-US-01 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE US 63/214,081 Abandoned
NIAID E-131-2020-8-US-07 Anti-Coronavirus Antibodies And Methods Of Use US CON 17/354,476 11447541 Issued PDF
NIAID E-131-2020-7-US-11 Anti-Coronavirus Antibodies And Methods Of Use US CON 17/354,434 1137-08-28 Issued PDF